Jean Yoon1, Gregg C Fonarow2, Peter W Groeneveld3, John R Teerlink4, Mary A Whooley4, Anju Sahay5, Paul A Heidenreich6. 1. Health Economics Resource Center, Veterans Affairs Palo Alto Health Care System, Menlo Park, California. Electronic address: jean.yoon@va.gov. 2. Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, California. 3. Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 4. Section of Cardiology, San Francisco Veterans Affairs Medical Center, San Francisco, California; Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, California. 5. Center for Innovation to Implementation, Veterans Affairs Palo Alto Health Care System, Menlo Park, California. 6. Center for Innovation to Implementation, Veterans Affairs Palo Alto Health Care System, Menlo Park, California; Stanford University School of Medicine, Stanford, California.
Abstract
OBJECTIVES: This study sought to determine the variation in annual health care costs among patients with heart failure in the Veterans Affairs (VA) system. BACKGROUND: Heart failure is associated with considerable use of health care resources, but little is known about patterns in patient characteristics related to higher costs. METHODS: We obtained VA utilization and cost records for all patients with a diagnosis of heart failure in fiscal year 2010. We compared total VA costs by patient demographic factors, comorbid conditions, and facility where they were treated in bivariate analyses. We regressed total costs on patient factors alone, VA facility alone, and all factors combined to determine the relative contribution of patient factors and facility to explaining cost differences. RESULTS: There were 117,870 patients with heart failure, and their mean annual VA costs were $30,719 (SD 49,180) with more than one-half of their costs from inpatient care. Patients at younger ages, of Hispanic or black race/ethnicity, diagnosed with comorbid drug use disorders, or who died during the year had the highest costs (all p < 0.01). There was variation in costs by facility as mean adjusted costs ranged from approximately $15,000 to $48,000. In adjusted analyses, patient factors alone explained more of the variation in health care costs (R(2) = 0.116) compared with the facility where the patient was treated (R(2) = 0.018). CONCLUSIONS: A large variation in costs of heart failure patients was observed across facilities, although this was explained largely by patient factors. Improving the efficiency of VA resource utilization may require increased scrutiny of high-cost patients to determine if adequate value is being delivered to those patients.
OBJECTIVES: This study sought to determine the variation in annual health care costs among patients with heart failure in the Veterans Affairs (VA) system. BACKGROUND: Heart failure is associated with considerable use of health care resources, but little is known about patterns in patient characteristics related to higher costs. METHODS: We obtained VA utilization and cost records for all patients with a diagnosis of heart failure in fiscal year 2010. We compared total VA costs by patient demographic factors, comorbid conditions, and facility where they were treated in bivariate analyses. We regressed total costs on patient factors alone, VA facility alone, and all factors combined to determine the relative contribution of patient factors and facility to explaining cost differences. RESULTS: There were 117,870 patients with heart failure, and their mean annual VA costs were $30,719 (SD 49,180) with more than one-half of their costs from inpatient care. Patients at younger ages, of Hispanic or black race/ethnicity, diagnosed with comorbid drug use disorders, or who died during the year had the highest costs (all p < 0.01). There was variation in costs by facility as mean adjusted costs ranged from approximately $15,000 to $48,000. In adjusted analyses, patient factors alone explained more of the variation in health care costs (R(2) = 0.116) compared with the facility where the patient was treated (R(2) = 0.018). CONCLUSIONS: A large variation in costs of heart failure patients was observed across facilities, although this was explained largely by patient factors. Improving the efficiency of VA resource utilization may require increased scrutiny of high-cost patients to determine if adequate value is being delivered to those patients.
Authors: Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz Journal: J Am Coll Cardiol Date: 2004-01-07 Impact factor: 24.094
Authors: Denise M Hynes; Kristin Koelling; Kevin Stroupe; Noreen Arnold; Katherine Mallin; Min-Woong Sohn; Frances M Weaver; Larry Manheim; Linda Kok Journal: Med Care Date: 2007-03 Impact factor: 2.983
Authors: Kathleen T Unroe; Melissa A Greiner; Adrian F Hernandez; David J Whellan; Padma Kaul; Kevin A Schulman; Eric D Peterson; Lesley H Curtis Journal: Arch Intern Med Date: 2010-10-11
Authors: Steven L Sayers; Nancy Hanrahan; Ann Kutney; Sean P Clarke; Brendali F Reis; Barbara Riegel Journal: J Am Geriatr Soc Date: 2007-08-21 Impact factor: 5.562
Authors: Paul A Heidenreich; Gregg C Fonarow; Yekaterina Opsha; Alexander T Sandhu; Nancy K Sweitzer; Haider J Warraich Journal: J Card Fail Date: 2022-01-24 Impact factor: 6.592
Authors: Shashank S Sinha; Nicholas M Moloci; Andrew M Ryan; Adam A Markovitz; Carrie H Colla; Valerie A Lewis; Brent K Hollenbeck; Brahmajee K Nallamothu; John M Hollingsworth Journal: Circ Cardiovasc Qual Outcomes Date: 2018-08
Authors: Andrea G Segal; Keri L Rodriguez; Judy A Shea; Kristina L Hruska; Lorrie Walker; Peter W Groeneveld Journal: J Am Heart Assoc Date: 2019-05-07 Impact factor: 5.501
Authors: Peter W Groeneveld; Elina L Medvedeva; Lorrie Walker; Andrea G Segal; Diane M Menno; Andrew J Epstein Journal: JAMA Netw Open Date: 2019-07-03
Authors: Mitali Stevens; Apeksha V Shenoy; Sibyl H Munson; Halit O Yapici; Boye L A Gricar; Xuan Zhang; Andrew D Shaw Journal: PLoS One Date: 2019-12-19 Impact factor: 3.240
Authors: Mitali Stevens; Todd Davis; Sibyl H Munson; Apeksha V Shenoy; Boye L A Gricar; Halit O Yapici; Andrew D Shaw Journal: Clinicoecon Outcomes Res Date: 2021-02-05
Authors: Alexander C Perino; Jun Fan; Susan K Schmitt; Daniel W Kaiser; Paul A Heidenreich; Sanjiv M Narayan; Paul J Wang; Andrew Y Chang; Mintu P Turakhia Journal: J Cardiovasc Electrophysiol Date: 2018-06-22
Authors: Michael Urbich; Gary Globe; Krystallia Pantiri; Marieke Heisen; Craig Bennison; Heidi S Wirtz; Gian Luca Di Tanna Journal: Pharmacoeconomics Date: 2020-11 Impact factor: 4.981